LexisNexis® Legal Newsroom
Ballard Spahr LLP
Third Circuit Denies Rehearing En Banc in Closely Watched Class Action

By Burt M. Rublin and Michael R. Carroll The U.S. Court of Appeals for the Third Circuit has denied a petition for rehearing en banc in a small-dollar consumer product class action. Depending on one’s perspective, this highly anticipated ruling...

DLA Piper
Federal Court Dismisses Lawsuit Against High-Fructose Corn Syrup Makers and GMO Labeling Moves Forward

By Stefanie Jill Fogel , Mary B. Langowski , and Tiffani V. Williams S.F. v. Archer-Daniels-Midland Co., No. 13-634, 2014 U.S. Dist. LEXIS 55195, [ enhanced version available to lexis.com subscribers ]. On April 21, the US District Court for...

GreenbergTraurig
Recent Changes to New York Election Law and Government Ethics Laws to Affect Organizations Involved in Political Advocacy as well as Public Officials

Continuing the recent trend, New York State has again enacted changes to New York’s election and government ethics laws in order to “restore public trust” in government. These “reforms,” which are likely to affect advocacy...

Foley & Lardner LLP
The People's Business Cannot Be Redacted: The Wisconsin Court of Appeals Directs a State Legislator to Release Withheld Email Information

In a potentially far-reaching decision, the Wisconsin Court of Appeals on April 9, 2014, put individuals, corporations, and others on notice that when they email a public official, their identities and email addresses are likely to be discoverable upon...

GreenbergTraurig
Social Media Photo Contest Draws FTC Attention: Endorsement/Testimonial Guidelines Apply

The FTC recently conducted an investigation of shoe manufacturer Cole Haan's "Wandering Sole" photo contest. The investigation focused on compliance with FTC guidelines requiring disclosure of material connections between an advertiser and...

Keller and Heckman LLP
FDA Finalizes Rule Prohibiting Certain Nutrient Content Claims for Omega-3 Fatty Acids

On April 28, 2014, the Food and Drug Administration (FDA) published a final rule that will prohibit certain nutrient content claims for foods and dietary supplements containing the omega-3 fatty acids docosahexaenoic acid (DHA), eicosapentaenoic acid...